Thematische Bibliographien / CD antigens

Auswahl der wissenschaftlichen Literatur zum Thema „CD antigens“

Autor: Grafiati
Veröffentlicht am 4. Juni 2021
Zuletzt aktualisiert am 28. Januar 2023

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "CD antigens" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Inhaltsverzeichnis

  1. Zeitschriftenartikel
  2. Dissertationen
  3. Bücher
  4. Buchteile
  5. Konferenzberichte

Zeitschriftenartikel zum Thema "CD antigens":

1

Mason, David, Pascale André, Armand Bensussan, Chris Buckley, Curt Civin, Edward Clark, Masja de Haas et al. „CD antigens 2001“. Journal of Leukocyte Biology 70, Nr. 5 (November 2001): 685–90. http://dx.doi.org/10.1189/jlb.70.5.685.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Kishimoto, T., S. Goyert, H. Kikutani, D. Mason, M. Miyasaka, L. Moretta, T. Ohno et al. „CD Antigens 1996“. Blood 89, Nr. 10 (15.05.1997): 3502. http://dx.doi.org/10.1182/blood.v89.10.3502.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Kishimoto, T., S. Goyert, H. Kikutani, D. Mason, M. Miyasaka, L. Moretta, T. Ohno et al. „CD Antigens 1996“. Blood 89, Nr. 10 (15.05.1997): 3502. http://dx.doi.org/10.1182/blood.v89.10.3502.3502_3502_3502.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Schlossman, SF, L. Boumsell, W. Gilks, JM Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, RL Silverstein und TA Springer. „CD antigens 1993“. Blood 83, Nr. 4 (15.02.1994): 879–80. http://dx.doi.org/10.1182/blood.v83.4.879.879.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Schlossman, SF, L. Boumsell, W. Gilks, JM Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, RL Silverstein und TA Springer. „CD antigens 1993“. Blood 83, Nr. 4 (15.02.1994): 879–80. http://dx.doi.org/10.1182/blood.v83.4.879.bloodjournal834879.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Schlossman, S. F., L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz et al. „CD Antigens 1993“. Leukemia & Lymphoma 13, sup1 (Januar 1994): 59–60. http://dx.doi.org/10.3109/10428199409052676.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Mason, D. Y., P. André, A. Bensussan, C. Buckley, C. Civin, E. Clark, M. De Haas et al. „CD antigens 2001“. Tissue Antigens 58, Nr. 6 (Dezember 2001): 425–30. http://dx.doi.org/10.1034/j.1399-0039.2001.580614.x.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Mason, David, Pascale André, Armand Bensussan, Chris Buckley, Curt Civin, Edward Clark, Masja de Haas et al. „CD Antigens 2001“. Modern Pathology 15, Nr. 1 (Januar 2002): 71–76. http://dx.doi.org/10.1038/modpathol.3880492.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Knapp, W., B. Dorken, P. Rieber, RE Schmidt, H. Stein und AE von dem Borne. „CD antigens 1989“. Blood 74, Nr. 4 (01.09.1989): 1448–50. http://dx.doi.org/10.1182/blood.v74.4.1448.1448.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Knapp, W., B. Dorken, P. Rieber, RE Schmidt, H. Stein und AE von dem Borne. „CD antigens 1989“. Blood 74, Nr. 4 (01.09.1989): 1448–50. http://dx.doi.org/10.1182/blood.v74.4.1448.bloodjournal7441448.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen
Die Auswahlen zum Thema "CD antigens" für konkrete Quellenarten können Sie auch interessieren:
Zeitschriftenartikel Dissertationen Bücher

Dissertationen zum Thema "CD antigens":

1

Osorio, Fernández Lyda María. „Regulation of T-cell proliferation and B-CLL apoptosis by CD6 and FAS/FASL /“. Stockholm, 1998. http://diss.kib.ki.se/search/diss.se.cfm?19980605osor.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Fernvik, Eva C. „Cell biological mechanisms and activity markers of eosinophils in relation to allergic inflammation /“. Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3399-5/.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Varelias, Antiopi. „Studies of CD44 variant isoform expression and function on activated human peripheral blood mononuclear cells and in renal transplantation“. Title page, summary and contents only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phv293.pdf.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Walter, Roland Bruno. „Mechanism of endocytosis of CD33/Siglec-3 : role of ITIMs, tyrosine phosphorylation, and monoubiquitylation /“. Thesis, Connect to this title online; UW restricted, 2006. http://hdl.handle.net/1773/6325.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Otipoby, Kevin L. „CD22 regulates B cell fate via two signaling domains within its cytoplasmic tail /“. Thesis, Connect to this title online; UW restricted, 2000. http://hdl.handle.net/1773/8335.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Misztela, Dominika. „The differential effects of CD80 and CD86 in helper T lymphocyte activation“. Thesis, University of Oxford, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670088.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Cheung, Chi-ho, und 張志豪. „Identification of CD47 as a novel therapeutic target for hepatocellular carcinoma“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46945374.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Dai, Tong. „Differential role of CEACAM1 and CEACAM2 in insulin metabolism“. Connect to full-text via OhioLINK ETD Center, 2004. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=mco1139336269.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Annotation:
Thesis (Ph.D.)--Medical University of Ohio, 2004.
"In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Medical Sciences." Major advisor: Sonia M. Najjar. Includes abstract. Document formatted into pages: v, 217 p. Title from title page of PDF document. Bibliography: pages 158-216.
9

Haas, Karen M. „Induction and regulation of bovine B lymphocyte responses“. free to MU campus, to others for purchase, 2000. http://wwwlib.umi.com/cr/mo/fullcit?p9999290.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Daoud, Roni N. „A study of MRP1-drug interactions : identification of the drug binding site(s)“. Thesis, McGill University, 2000. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=36801.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Annotation:
Over-expression of either P-gp1 and/or MRP1 in tumor cell lines confers resistance to structurally diverse anti-cancer drugs. Although the role of these two proteins in clinical drug resistance remains to be confirmed, the use of Pgp1-specific inhibitors in combination with standard anti-cancer drugs have demonstrated significant improvement in clinical response. However, evidence exists that reversal of P-gp1 alone is not sufficient. Therefore, while no drugs are currently available that can efficiently reverse MRP1 drug efflux in tumor cells, there is an urgent need to develop MRP1-specific blockers. In an effort to gain a better understanding of MRP1-drug interactions and to identify sequences within MRP1 that interact directly with drugs, we developed two structurally diverse photosensitive drug analogues, a quinoline-based compound (IACI) and a xanthone-derivative (IAARh123). Both compounds photolabeled MRP1 and showed a direct and specific interaction with the protein at physiologically relevant sites. Initial mapping of photolabeled sequences in MRP1 (Chapters 2 and 3), identified multiple IACI- or IAARh123-photolabeled peptides (∼4--7 kDa) derived from both the N-terminal (MSD0+MSD1+NBD 1) and C-terminal (MSD2+NBD2) domains of MRP1. A subsequent study (Chapter 4), using MRP1 variants with hemagglutinin (HA) epitopes inserted at eight different locations, led to a higher resolution mapping of the previously identified IACI- or IAARh123-labeled peptides. Specifically, two photolabeled peptides (∼6--7 kDa), derived from variants with insertions at positions 574 and 1222, were immunoprecipitated with anti-HA monoclonal antibody. Based on the location of the HA epitopes in the latter variants together with molecular masses of the two peptides, the photolabeled amino acid residues were localized to MRP1 sequences encoding transmembranes 10 and 11 of MSD1 and transmembranes 16 and 17 of MSD 2. Interestingly, the same sequences were photolabeled with both
Mehr Quellen

Bücher zum Thema "CD antigens":

1

Kapil, Mehta, und Malavasi Fabio, Hrsg. Human CD38 and related molecules. Basel: Karger, 2000.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

A, Herzenberg Leonore, Haughton Geoffrey und Rajewsky K. 1936-, Hrsg. CD5 B cells in development and disease. New York, N.Y: New York Academy of Sciences, 1992.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

name, No. Ectopeptidases: CD13/aminopeptidase N and CD26/dipeptidylpeptidase IV in medicine and biology. New York, NY: Kluwer Academic/Plenum, 2003.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Lieping, Chen, Hrsg. The B7-CD28 family molecules. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2003.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Tadamitsu, Kishimoto, und International Workshop and Conference on Human Leucocyte Differentiation Antigens (6th : 1996 : Kobe-shi, Japan), Hrsg. Leucocyte typing VI: White cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub., 1998.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Yona, Simon. Adhesion-GPCRs structure to function. New York, N.Y: Springer Science+Business Media, 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

1953-, Gordon J., Hrsg. CD23--a novel multifunctional regulator of the immune system that binds IgE. Basel: Karger, 1991.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Okudela, Koji. Cancer stem cells in lung cancer. Hauppauge, N.Y: Nova Science Publishers, 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Chen, Lieping. CD137 Pathway: Immunology and Diseases. Springer, 2006.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Chen, Lieping. CD137 Pathway: Immunology and Diseases. Springer, 2014.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Buchteile zum Thema "CD antigens":

1

Christopherson, Richard I. „CD Antigens“. In Encyclopedia of Cancer, 1–6. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_947-2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Christopherson, Richard I. „CD Antigens“. In Encyclopedia of Cancer, 842–46. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-46875-3_947.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Ward, Tony Milford. „CD Antigens (Soluble)“. In Proteins and Tumour Markers May 1995, 1001–9. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0681-8_24.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Kropshofer, Harold, Claudia Müller und Hubert Kalbacher. „Fluorescence and CD-spectrometric use of specifically labeled peptide antigens interacting with HLA-DR 1“. In Peptides 1990, 892–94. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3034-9_366.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Gorga, Joan C., Aichun Dong, Mark C. Manning, Robert W. Woody, Winslow S. Caughey und Jack L. Strominger. „Comparison of the Secondary Structures of Human Class I and Class II MHC Antigens by Ftir and CD Spectroscopy“. In Protein Structure and Engineering, 355–65. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4684-5745-2_23.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Żeromski, Jan, Renata Jenek, Zofia Niemir und Wlodzimierz Liebert. „CD 56 (N-CAM) antigen and mRNA expression in human endocrine glands“. In Advances in Experimental Medicine and Biology, 335–39. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-0685-0_47.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Majer, Zs, S. Holly, G. K. Tóth, Gy Váradi, I. Laczkó, É. Rajnavölgyi und M. Hollósi. „Conformational mapping of the antigenic intersubunit region of influenza virus hemagglutinin: CD and FTIR spectroscopy studies“. In Peptides 1994, 545–46. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-1468-4_247.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Hołowiecki, J., D. Lutz, S. Krzemień, F. Graf, G. Keleney, M. Brugiatelli, V. Callea et al. „Expression of CD-15 Antigen on Leukemic Cells — A New Prognostic Factor for Ability to Achieve Complete Remission and for Survival in ANLL“. In Acute Leukemias, 361–64. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71213-5_59.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Stockinger, Hannes, Otto Majdic und Walter Knapp. „CD Antigens“. In Encyclopedia of Immunology, 444–57. Elsevier, 1998. http://dx.doi.org/10.1006/rwei.1999.0118.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

„CD Antigens“. In Encyclopedia of Cancer, 689–92. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_947.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "CD antigens":

1

Wernet, P., E. M. Scheider, P. Sarin, P. Chandra, H. H. Brackmann, M. Kessler und H. Egli. „Demonstration of HIV-encoded Proteins in Cultured and in Uncultured CD 4 Positive Mononuclear Cells from Hemophilia Patients Employing Monoclonal Antibodies against p 15, p 24, GP 41, GP 120, and Reverse Transcriptase“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644683.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Annotation:
In the light of the large percentage of hemophilia patients with antibodies to HIV the identification of a specific virus infection in comparison to HIV antibody negative hemophilia patients has reached crucial importance. The low success rates of direct virus culture techniques together with the as yet low AIDS-di-sease rate observed in these patients separate these patients from the other main risk groups. Within this context, we studied the expression of CD3, CD4, CD8, and HLA class II antigens on fixed cells after PHA stimulation and Interleukin 2 propagation as well as on untreated blood mononuclear cells from healthy individuals and from hemophilia patients by fluorescence activated flow cytometry. Monoclonal antibodies thought to be specific for p 15, p 24, GP 41, GP 120, and for reverse transcriptase revealed a certain number of positive cells on all defined subpopulations analysed. From cell specimen of HIV antibody positive hemophilia patients cells with specific HIV antigens could be enriched by in vitro cultivation. Importantly the expression of virus-encoded antigens preceedes a cytopathic effect for several daVs. Current analyses aim at the prognostic relevance of low amounts of such viral HIV proteins selectively detectable by moAbs.directed to either p 24, GP 41, GP 120, and RT. The reliability, high sensitivity and monoclonal antibody dependent specificity of this newly developed method for the demonstration of HIV specific proteins make it applicable also for longitudinal surveys of hemophilia patients to assess a potential state of viremia or virus antigen processing in their mononuclear cells.
2

Nagata, H., S. Nomura, K. Oda, T. Kokawa und K. Yasunaga. „ANALYSIS OF THE FUNCTIONAL ROLE OF PLATELET MEMBRANE GLYCOPROTEINS WITH MONOCLONAL ANTIBODIES“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643509.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Annotation:
Eight monoclonal antibodies were obtained which recognized platelet surface antigens of these, 5 (NNKYl-32, NNKY2-5, NNKY2-6, NNKY2-11, NNKY2-18 ) recognized GP IIb-IIIa complex, 2 (NNKY5-4, NNKY5-5 ) recognized GP lb and 1 (NNKYl-19) recognized CD 9 antigen. They were used to research the platelet membrane antigens.Monoclonal antibodies that recognize CD 9 antigen, which exists on the surface of platelets, acute lymphoblastic leukemia cells, eosinophils and other tissue, are known to act as an aggregating agent to platelets and NNKYl-19 was fond to induce platelet aggregation accompanied by ATP release. NNKY5-4 had no effect on platelet functions. NNKY5-5 inhibited aggregation induced by ristocetin but had no effect on aggregation induced by ADP, collagen, thrombin, and NNKYl-19. NNKYl-32, 2-5, 2-6, 2-11, and 2-18 inhibited aggregation induced by ADP, collagen, thrombin, and NNKYl-19, although slight release of ATP was recognized when NNKYl-19-induced aggregation was completely inhibited by NNKYl-32. Mutual inhibition of binding to platelet membranes between the 3 groups of monoclonal antibodies was not recognizedNNKYl-19-induced aggregation was associated with a lag time that was plo-longed in inverse proportion to antibody concentration. Aspirin had almost no effect on NNKYl-19-induced aggregation. A TXA2 receptor antagonist, a calci-um-channel blocking drug and EDTA inhibited NNKYl-19-induced aggregation. These results indicate that GP I b, GP IIb-IIIa complex and the cyclooxygenase pathway are not involved in NNKYl-19-induced platelet activation, that the target of NNKYl-19 on the platelet membrane is same as that of TXA2, and that the mechanism of activation by NNKYl-19 is related to calcium flux.
3

Chen, Kui, Laurie Ailles, John E. Dick und Anand Ghanekar. „Abstract 3476: Profiling CD antigens signature in human hepatocellular carcinoma (HCC) by cell-based high-throughput screening flow cytometry (HTS-FC)“. In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3476.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Damjanovich, Sandor, Laszlo Balkay, Laszlo Pohubi, Tamas Varhelyi, Laszlo Bene, Adorjan Aszalos, Laszlo Matyus und Lajos Tron. „Mobility of HLA Class I antigen influenced by anti-CD-4 monoclonal antibody in lymphocyte membranes: a flow cytometric energy transfer, fluorescence photobleaching recovery, and rotational relaxation study“. In OE/LASE '90, 14-19 Jan., Los Angeles, CA, herausgegeben von Joseph R. Lakowicz. SPIE, 1990. http://dx.doi.org/10.1117/12.17744.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Hwang, Sujin, Heba Degheidy, Mondona McCann, Steven Bauer, Raj Puri und Bharat Joshi. „344 Comparative assessment of product quality attributes associated with production of chimeric antigen receptor T cells expressing scFv CD-19 and scFv IL-13Ra2 by two manufacturing platforms“. In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0344.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Ranu, Harpreet, Omar Jallow, Yanwen Hou, Gary Coulton und Brendan Madden. „New Insights Into Pulmonary Hypertension Associated With Sickle Cell Disease-A Role For CD 40 Antigen, Tumour Necrosis Factor Receptor Like 2, Heart-Type Fatty Acid Binding Protein And Beta 2 Microglobulin“. In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1989.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Zur Bibliographie